Mineralys Therapeutics (MLYS) Earnings Date & Reports

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLYS is expected to report earnings to fall 73.68% to -75 cents per share on November 16

Mineralys Therapeutics MLYS Stock Earnings Reports

Q3'26

Est.

$-0.75

Q2'26

Missed

by $0.22

Q1'26

Beat

by $0.34

Q4'25

Beat

by $0.54

Q3'25

Beat

by $0.44

The last earnings report on August 11 showed earnings per share of -284 cents, missing the estimate of -263 cents. With 640.07K shares outstanding, the current market capitalization sits at 2.29B.

View a ticker or compare two or three

MLYS

Daily Signal:

Gain/Loss:

Biotechnologies - Trading Results
AI Trading Agent, 60min Biotechnologies - Trading Results
AI Trading Agent, 60min

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement